CSR and the Cash Register

Kaushik, Manu
February 2008
Business Today;2/10/2008, Vol. 17 Issue 3, p46
The article focuses on Jubilant Organosys Ltd., the only Indian company getting top rating in the report on Corporate Social Responsibility (CSR) in action in emerging economies by International Finance Corporation (IFC). It states about the positive financial results of the company after the IFC's report, "Market Movers: Lessons from a Frontier of Innovation," showing that it pays to build CSR into one's business model.


Related Articles

  • Jubilant Organosys gets award.  // Chemical Business;Sep2007, Vol. 21 Issue 9, p73 

    The article announces that Jubilant Organosys has received an award for its commitment to corporate sustainability from Global Reporting Initiative, an international agency developing sustainability reporting guidelines.

  • specialty chemicals & APIs.  // Chemical Week;2/19/2003, Vol. 165 Issue 7, p70 

    Profiles Jubilant Organosys Ltd., the largest specialty chemicals company in India. Services offered by the company to the pharmaceutical and the agrochemicals industries; Divisions of the company; Information on the manufacturing plants of Jubilant.

  • Jubilant focuses on life sciences. Hariharan, Malini; Viswanathan, Prema // Asian Chemical News;10/24/2005, Vol. 11 Issue 511, p8 

    Focuses on the decision of Jubilant Organosys to increase its share of the pharmaceuticals and life sciences sector in India in 2005. Performance of the pharmaceuticals and life sciences sector in the financial year ended March 31, 2005; Merger and acquisition activities of the company;...

  • Jubilant to raise $55m for growth. Tong, Alfred // Asian Chemical News;2/23/2004, Vol. 10 Issue 434, p9 

    Reports on the plans of chemical manufacturer Jubilant Organosys to raise $55 million on the global capital market in an effort to fund its growth plans in February 2004. Increase in the capacity of the oxycarbazepine plant in Nanjangud, India being planned by the company; Reason for the...

  • Jubilant focuses on life sciences. Hariharan, Malini // Chemical Market Reporter;10/31/2005, Vol. 268 Issue 15, p16 

    Reports on the transformation of the pharmaceuticals and life science firm, Jubilant Organosys Ltd., in India. Financial performance; Increase in the market share of the firm; Growth of the company.

  • India's Jubilant Makes a U.S. Acquisition. Scott, Alex // Chemical Week;7/13/2005, Vol. 167 Issue 23, p36 

    Reports on the move of Jubilant Organosys, the largest contract research and manufacturing services in India, to acquire a 64% state in generic drugs group Trinity Laboratories of Maryland. Details on the acquisition deal; Additional amount of investment which Jubilant will put into the generic...

  • Jubilant Organosys posts 40% growth in Q3 net.  // Chemical Business;Feb2008, Vol. 22 Issue 2, p66 

    This article reports on the financial performance of Jubilant Organosys in the third quarter of 2007. Jubilant posted an increase in consolidated net profits during the period. Chairman and managing director Shyam S. Bhartia attributed the growth the expansion of the business. The industrial and...

  • Indian Firms Record Extraordinary Growth. Ramesh, Deepti // Chemical Week;1/31/2007, Vol. 169 Issue 4, p21 

    The article reports on the financial performance of Indian pharmaceutical and fine chemical companies in 2006. India's largest pharma company, Ranbaxy Laboratories, has recorded a doubling of net profit to $117 million in 2006, on sales up 17%, to $1.36 billion. Another top pharma company,...

  • Strides, Jubilant among cos setting up new units in Karnataka.  // Chemical Business;Oct2005, Vol. 19 Issue 10, p84 

    Reports on several companies that are planning to set up plants in Karnataka, India in 2005. Strides Arcolab; Jubilant Organosys; Star Drugs & Research Labs.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics